Pharmaffiliates - A Perfect Outsourcing Partner

Published August 24, 2021 by pharmaffiliates

CRAMS or Contract Research and Manufacturing Services, which is the newest, fastest growing and the most sought after segment in Pharmaceutical world.

In the Indian subcontinent,contract manufacture and research services (CRAMS) industry has witnessed tremendous growth, owing to a wide ranging product mix consisting of high-end research services, biologics, and complex technology services, all offered at a low cost. India presents a strong case,with externalization of research to emerging markets, for outsourcing research and manufacturing.

2It is also imperative to provide these services in line with international regulatory norms like the USFDA, Australian-TGA, UKMCA, and EMEA. India is amongst the preferred destinations for outsourcing of research as well as manufacturing activities due to the presence of large number of US FDA approved manufacturing facilities.

Globally, drug manufactures are extremely cautious about investments in new technologies, equipment, facilities and skilled labor. Preferring to outsource, rather than incur heavy capital costs of building, expanding or upgrading their own internal capabilities stimulates the growth of contract research and manufacturing in India and other Asian countries like China and Singapore.

To grab a greater share of CRAMS pie, Indian companies need to keep the cost under control, to deliver just in time and to manage the efficiency and quality. In a survey it is speculated that India’s cost of production is 33% lower than in the USA and half of that of Europe.

Indian CRAMS giants have expected to reach 40bn USD by 2030. With number of schemes provided by the Indian Government, it was found that in 2020 every one out of ten-medicine available in the market was discovered in India and India is among the top five Pharmaceutical innovative hub across the world.

One such leading and fast growing CRO in India, which has marveled its name worldwide, is Pharmaffiliates Analytics and Synthetics P. Ltd.

Pharmaffiliates is a reliable and preferred CRAMS partner in providing innovative Pharmaceutical solutions. We are equipped with a state of art Research and Development department, along with a core team of scientists having an expertise in chemistry. The R & D department is equipped with high end modern analytical instruments and provision is also made for scale up processes.

Apart from a strong R & D team, Pharmaffiliates has independent Quality Assurance, Regulatory affairs and Supply Chain management departments also. These independent teams move hand in hand with each other to accelerate the efficiency of R & D department so that they can provide their clients with timely deliveries, keeping in view the cost competency and Environmental and Health safety compliance also.IP protection and confidentiality of the project is fully taken care of at Pharmaffiliates.

Reasons for choosing Pharmaffiliates as CRAMS partner

• US FDA audited and accepted analytical facility
• Advisory committee includes core team of scientists with immense corporate experience
• 24*7 service support assistance
• Direct communication with technical team anytime during the project
• Paperless monitoring through ERP software
• Strong and transparent quality assurance process
• Confidentiality, Data accuracy, Data integrity, Data reproducibility is safeguarded
• FTE (Full time equivalent) and FFS (Feeforservice)based projects
• 50+ projects already delivered successfully across the globe

Apart from this, Pharmaffiliates offers early phase drug development, process research and development, Custom chemical synthesis (CCS) and Regulatory submission support.

With unwavering commitment to quality, state-of-the-art research, regulatory and intellectual property (IP) expertise, Pharmaffiliates as a CRO is geared up to support and accelerate the research & development of global innovator companies.

Pharmaffiliates offers a vast array of services while maintaining high quality standards and efficient timelines.